FMR LLC 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:30 am Sale | 2024-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 2,467,809 3.500% | -1,911,010 (-43.64%) | Filing |
| 2024-11-12 10:32 am Sale | 2024-11-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 4,378,819 6.207% | -715,910 (-14.05%) | Filing |
| 2024-03-11 08:19 am Sale | 2024-03-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 5,094,729 7.562% | -1,907,379 (-27.24%) | Filing |
| 2024-02-09 09:28 am Purchase | 2024-02-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 7,002,108 12.835% | 2,985,500 (+74.33%) | Filing |
| 2023-02-09 12:01 pm Sale | 2023-02-09 | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 4,016,608 10.148% | -1,890,671 (-32.01%) | Filing |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC | FMR LLC | 5,907,279 14.999% | 454,932 (+8.34%) | Filing |